United States Food and Drug Administration (USFDA) - BioResearch Monitoring Program (BIMO) Conducted Two Inspections at Veeda CR - Ahmedabad

Manish Arya / On 2017-11-09 05:38:54

Veeda CR is glad to share the successful completion of 2 USFDA Inspections at two of its locations at Ahmedabad in Sep-2017. Both the Inspections were Routine Inspections by BIMO (BioResearch Monitoring Program - USFDA) covering Clinical Phase of Healthy Volunteer BE studies.

The outcome of both the Inspections was - no issues identified in the studies conducted at Veeda facilities, i.e. No 483.

Veeda CR has faced 18 USFDA Inspections in last 24 months out of which 14 were clinical trial site inspections and four were for Healthy volunteer BE studies. Out of four Healthy volunteer BE study inspections, two were from the Office of Study Integrity and Surveillance and two were from BIMO (BioResearch Monitoring Program - USFDA). We are glad to share that 17 out of these 18 USFDA Inspections got concluded with No 483, which demonstrates our commitment levels towards Quality and Regulatory Compliance.

With an enhanced focus on 'Right First Time' approach, Veeda CR looks forward to a brighter future in Clinical Research Arena. These inspections are another testimony to Veeda CR's continuous quality review and improvement measures institutionalized into the work culture, by our visionary and a highly quality conscious Management.

Related Stories